Karela is a herbal preparation derived from momordica charantia that is used to lower blood glucose levels in patients with type 2 diabetes. Its definition refers to a standardized dried fruit extract containing active polysaccharides and polypeptide-p. The mechanism of action includes stimulation of insulin secretion from pancreatic beta cells and inhibition of hepatic gluconeogenesis. It also enhances peripheral glucose uptake by promoting translocation of glucose transporters in muscle cells. The compound exerts anti-inflammatory effects through modulation of cytokine pathways. These actions collectively improve glycemic control without causing severe hypoglycemia when used appropriately. Clinical studies have shown that regular supplementation reduces fasting plasma glucose and improves insulin sensitivity. Efficacy is greatest when Karela is used alongside lifestyle modifications and standard antidiabetic therapy.

Karela, derived from the fruit of momordica charantica, is used in certain traditional medicinal formulations as an adjunct therapy for metabolic disorders. Its pharmacological profile includes a mixture of bioactive compounds such as charantin, polypeptide-p, and momordicin that exhibit hypoglycemic activity. These compounds influence insulin secretion from pancreatic beta cells and enhance peripheral glucose uptake in muscles. The stimulation of insulin release is mediated through activation of calcium channels and modulation of the camp signaling pathway. Simultaneously, the plant constituents inhibit hepatic gluconeogenesis by down-regulating key enzymes such as glucose-6-phosphatase. This dual action reduces circulating glucose levels while also improving lipid metabolism through alterations in fatty acid oxidation. In vivo studies have shown that chronic administration leads to decreased fasting blood sugar and improved insulin sensitivity in animal models. Overall, the therapeutic effect of Karela stems from its ability to concurrently modulate multiple steps of the glucose regulatory network.

Karela may cause stomach discomfort in some people. Consumption can lead to mild nausea or dizziness occasionally. It has been reported to lower blood sugar levels which may affect medication effectiveness. In rare cases allergic skin reactions such as rash or itching may occur. Some individuals experience diarrhea or loose stools after eating Karela. Overconsumption can result in excessive thirst or dry mouth. The fruit may interact with certain herbal supplements causing unexpected changes in energy levels. Long term high intake might affect liver function tests in susceptible individuals.

Karela is commonly consumed as a vegetable in various cuisines. Some individuals may experience gastrointestinal discomfort such as nausea or abdominal cramping after eating it. In rare cases, excessive intake has been linked to hypoglycemia due to its blood sugar-lowering compounds. The fruit can interact with antidiabetic medications, potentially amplifying their effects. Mild skin irritation may occur in sensitive individuals when handling the raw fruit. Overconsumption can also lead to diarrhea or loose stools in certain people. These reactions are generally mild and occur in a small proportion of the population.